Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days
Deals·Baba

Baba raises $40M to coordinate care for Medicare patients with human teams and AI

FirstMark Capital led the Series A, joined by CVS Health Ventures and Valtruis. The New York company says it has more than 100,000 families on a waiting list and was picked for all four tracks of CMS's ACCESS Model.

Charted Staff2 min read
From a company announcement published Oct. 20, 2026, via GlobeNewswire (reprinted by Santé Log), and HLTH coverage of the company's February 2026 seed round
Kathleen Sebelius, then secretary of health and human services, greets seniors at the Arthur Capper Senior Apartment Building in Washington during a 2010 visit about Medicare open enrollment.
Kathleen Sebelius, then secretary of health and human services, greets seniors at the Arthur Capper Senior Apartment Building in Washington during a 2010 visit about Medicare open enrollment. File photo.U.S. Department of Health and Human Services (public domain)
Amount
$40M
Type
Series A
Company
Baba
Lead investor
FirstMark Capital
Sector
Digital Health
Announced
Oct. 20, 2026

Nearly 70 million Americans are on Medicare, and Baba says many of them depend on a relative to keep doctors, pharmacies and benefits straight. The New York company, which gives each patient a care team backed by AI, said Oct. 20 that it raised $40 million in a Series A round led by FirstMark Capital.

CVS Health Ventures and Valtruis came in as new investors, and General Catalyst, Genius Ventures and Ground Up Ventures returned, the company said. Baba did not disclose a valuation.

Why it matters: Baba's case rests on cost. It argues that AI can bring down the expense of coordinating care for Medicare and Medicaid patients with complex needs, and it plans to sell that model to more health plans and through value-based arrangements.

Connor Sweeney, the founder and chief executive, said lower costs create "an opportunity to make care delivery economically viable for populations that have historically been too expensive to serve."

How the model works

Each patient is assigned a care team that includes licensed therapists and care coordinators, according to the company. Baba said those teams handle hospital discharges, specialist visits, in-home help, behavioral health and practical needs such as housing and transportation, with AI working alongside licensed clinicians and coordinators.

Baba said it has supported over 10,000 patients and their families so far, and it reports a waiting list of over 100,000 families.

The company argues the job is getting harder. It said the number of specialists seen annually by the average Medicare patient has climbed by over 40% in 20 years, and that over 63 million Americans now serve as family caregivers, 20 million more than 10 years ago.

In June, according to Baba, the Centers for Medicare & Medicaid Services chose it for the ACCESS Model, which the company describes as a 10-year CMS Innovation Center test of chronic care supported by technology. Baba said it was picked for all four clinical tracks: early cardio-kidney-metabolic, cardio-kidney-metabolic, musculoskeletal and behavioral health.

Baba has also published BabaBench, a benchmark it built to test whether AI agents can carry long patient advocacy jobs, such as paperwork, calls with insurers and billing problems, all the way to completion without privacy violations or prohibited actions.

Carter Prince, a partner at CVS Health Ventures, stressed the human side of the model. "Navigating healthcare is not a challenge that can be solved by general AI agents," Prince said in the release.

What comes next

Baba said it will use the money to expand its clinical care teams, push its AI research further, add health plan customers and grow its value-based arrangements. It has also hired Alicia Tennenbaum, a licensed clinical social worker who previously worked at Mount Sinai, to run clinical operations as executive director.

The Series A comes eight months after Baba came out of stealth in February with a seed round of more than $6.5 million, led by General Catalyst, HLTH reported at the time. The company said it works with national health plans but did not name them or disclose revenue.

Stories bylined Charted Staff are produced by the Charted newsroom from public documents: company announcements, SEC filings, FDA databases and federal rules. Each one lists the documents it was drawn from. Drafted with automated tools from the sources listed with this story and checked against them before publishing. How we report.

More Deals

More
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.